CH5132799 T2619
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CH5132799 has been used in trials studying the treatment of Solid Tumors.
CAS nr:
1007207-67-1
Purity:
98%
Molecular Weight:
377,42
SMILES:
CS(=O)(=O)N1CCc2c(nc(nc12)N1CCOCC1)c1cnc(N)nc1
Formula:
C15H19N7O3S
Pathway:
PI3K/Akt/mTOR signaling,PI3K/Akt/mTOR signaling
Target:
PI3K,mTOR
